Amino acids are fundamental materials composing our body protein and life activities, and they have two distinct aspects, nutritional and physiological functions within our body. For medical use of amino acids, we know a variety of amino acid elemental diets, such as the Elental liquid diet, that effectively supply essential amino acids without digestion, and they have been used based on their nutritional benefits (1). In contrast, behind the recent health trend in utilizing amino acids, the physiological function specific for each amino acid has been extensively investigated and investigators have tried to use this information to develop suitable amino acid preparations for medical treatment. The most famous amino acid may be glutamine, for which a therapeutic effect was originally discovered by Okabe and Takeuchi (2) . Now, glutamine is well known as a functional amino acid in clinics to treat gastrointestinal mucosal disorders (3) . Discoveries of amino acid transporters and specific receptors in the brain, gut, kidney, and skeletal muscle have suggested those molecules as therapeutic targets and accelerated the application of the amino acid itself for medicine. We have summarized recent trials in amino acid medicine in Table 1 .
Nonessential amino acid glutamate and glycine are known to act as major neurotransmitters within the brain. Recently, receptors recognizing glutamate and glycine were identified in the peripheral tissues such as taste and digestive organs (4 -6) . It has been reported that supplementation of glutamate improved gastrointestinal functions (motility and mucus secretion), leading to the hypothesis that glutamate may prevent gastro-duodenal ulcer and functional dyspepsia (7, 8) . Bannai et al. has clearly suggested that glycine intake before bedtime can improve the quality of sleep and glycine could be used as a medicine for patients with sleep disorders (9) . Clinical evidence for the effectiveness of essential amino acids, branched chain amino acids (BCAAs, for treating sarcopenia in the elderly has been accumulated as well (10) .
At the 84th Annual Meeting of The Japanese Pharmacological Society, Yokohama, March 2011, we held a symposium to review issues associated with current therapeutic strategy of new amino acid medicine. As the proceedings of our symposium, we chose typical candidates for functional amino acids (glutamine, glutamic acid, glycine, BCAA) and discussed their possible clinical use to prevent or treat gastrointestinal, eating, and sleep disorders and muscle sarcopenia (11 -14) . We hope this Forum Minireview series will prompt investigators to start thinking of new strategies for amino acid medicine. 
